US Equity
RIGL
— RIGEL PHARMACEUTICALS, INC.Rigel Pharmaceuticals, Inc. is a biotechnology company that develops and commercializes small molecule drugs for the treatment of hematologic disorders and cancer.
💰 Market cap: $691.79M📍 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080 US🏷️ Pharmaceuticals💵 Previous close: $36.74🔢 5,492 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $36.74 |
| 2026-07-23 | $36.82 |
| 2026-07-22 | $37.80 |
| 2026-07-21 | $39.31 |
| 2026-07-20 | $39.67 |
| 2026-07-17 | $40.54 |
| 2026-07-16 | $41.67 |
| 2026-07-15 | $41.18 |
| 2026-07-14 | $41.17 |
| 2026-07-13 | $41.30 |
| 2026-07-10 | $42.55 |
| 2026-07-09 | $43.76 |
| 2026-07-08 | $42.93 |
| 2026-07-07 | $42.56 |
| 2026-07-06 | $40.26 |
| 2026-07-02 | $38.72 |
| 2026-07-01 | $38.29 |
| 2026-06-30 | $39.12 |
| 2026-06-29 | $39.04 |
| 2026-06-26 | $38.69 |
| 2026-06-25 | $36.99 |
| 2026-06-24 | $36.55 |
| 2026-06-23 | $35.61 |
| 2026-06-22 | $35.73 |
| 2026-06-18 | $32.91 |
| 2026-06-17 | $33.37 |
| 2026-06-16 | $32.46 |
| 2026-06-15 | $33.42 |
| 2026-06-12 | $32.85 |
| 2026-06-11 | $32.08 |
| 2026-06-10 | $30.91 |
| 2026-06-09 | $30.72 |
| 2026-06-08 | $30.08 |
| 2026-06-05 | $29.93 |
| 2026-06-04 | $30.25 |
| 2026-06-03 | $30.30 |
| 2026-06-02 | $30.02 |
| 2026-06-01 | $29.86 |
| 2026-05-29 | $30.49 |
| 2026-05-28 | $30.05 |
| 2026-05-27 | $29.48 |
| 2026-05-26 | $29.17 |
| 2026-05-22 | $29.01 |
| 2026-05-21 | $29.19 |
| 2026-05-20 | $28.82 |
| 2026-05-19 | $28.30 |
| 2026-05-18 | $28.61 |
| 2026-05-15 | $29.01 |
| 2026-05-14 | $31.92 |
| 2026-05-13 | $32.13 |
| 2026-05-12 | $29.37 |
| 2026-05-11 | $26.20 |
| 2026-05-08 | $26.04 |
| 2026-05-07 | $26.24 |
| 2026-05-06 | $26.67 |
| 2026-05-05 | $28.09 |
| 2026-05-04 | $29.54 |
| 2026-05-01 | $29.40 |
| 2026-04-30 | $28.90 |
| 2026-04-29 | $29.22 |
| 2026-04-28 | $30.56 |